You are here

Home

Clinical Trials: Myocardial Ischemia

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Friday, April 10, 2020 - 12:00
ASC Therapy for Patients With Severe Respiratory COVID-19
Condition:   Respiratory Tract Diseases
Intervention:   Drug: Stem Cell Product
Sponsor:   Rigshospitalet, Denmark
Not yet recruiting
Posted: Thursday, April 9, 2020 - 12:00
Stem Cell in Acute Myocardial Infarction
Condition:   Acute Myocardial Infarction
Intervention:   Biological: Mesenchymal Stem Cells
Sponsor:   PT. Prodia Stem Cell Indonesia
Recruiting
Posted: Tuesday, March 31, 2020 - 12:00
Safety Evaluation of Intracoronary Infusion of Extracellular Vesicles in Patients With AMI
Condition:   Heart Attack
Intervention:   Drug: PEP in Acute Myocardial Infarction
Sponsor:   Paul G. Stalboerger
Not yet recruiting
Posted: Wednesday, August 14, 2019 - 12:00
Evaluate the Safety and Explore Efficacy of Umbilical Cord Mesenchymal Stem Cells in Acute Myocardial Infarction
Condition:   Acute Myocardial Infarction
Intervention:   Biological: Allogeneic umbilical cord mesenchymal stem cells
Sponsor:   Ever Supreme Bio Technology Co., Ltd.
Recruiting
Posted: Friday, August 9, 2019 - 12:00
MCRcI® Stem Cell Treatment for Diffuse Coronary Artery Disease
Condition:   Coronary Artery Disease
Intervention:   Biological: MCRcI® stem cells
Sponsors:   Honya Medical Inc;   Chang Gung Memorial Hospital
Recruiting
Posted: Thursday, August 8, 2019 - 12:00
MiSaver® Stem Cell Treatment for Heart Attack (Acute Myocardial Infarction)
Condition:   Myocardial Infarction
Intervention:   Biological: MiSaver®
Sponsors:   Honya Medical Inc;   Chung Shan Medical University
Recruiting
Posted: Thursday, May 16, 2019 - 12:00
Randomized Clinical Comparison of the Combined Sirolimus Eluting and Endothelial Progenitor Cell Combo™ Stent and the Biolimus Eluting Absorbable Polymer Coated BioMatrix Alpha™ Stent in Patients Treated With Percutaneous Coronary Intervention
Condition:   Coronary Artery Disease
Interventions:   Combination Product: PCI with BioMatrix Alpha™ stent;   Combination Product: PCI with Combo™ stent
Sponsors:   Phillip Freeman;   Aarhus University Hospital;   Odense University Hospital;   OrbusNeich;   Biosensors International
Not yet recruiting
Posted: Wednesday, April 24, 2019 - 12:00
Serial Infusions of Allogeneic Mesenchymal Stem Cells in Ischemic Cardiomyopathy Patients With Left Ventricular Assist Device
Condition:   Ischemic Heart Disease
Interventions:   Biological: Human Allogeneic Mesenchymal Bone Marrow Cells (aMBMC);   Other: Placebo
Sponsor:   Rebecca Torguson
Not yet recruiting
Posted: Wednesday, April 3, 2019 - 12:00
UC-MSC Transplantation for Left Ventricular Dysfunction After AMI
Conditions:   Left Ventricular Dysfunction;   Acute Myocardial Infarction
Interventions:   Biological: UC-MSC;   Biological: Control Group
Sponsors:   Shanghai Life Science & Technology;   Shanghai Jiao Tong University Affiliated Sixth People’s Hospital
Not yet recruiting
Posted: Wednesday, January 9, 2019 - 12:00
Pericardial Matrix With Mesenchymal Stem Cells for the Treatment of Patients With Infarcted Myocardial Tissue
Condition:   Myocardial Infarction
Interventions:   Combination Product: PeriCord: Expanded and cryopreserved allogeneic umbilical cord Wharton´s jelly-derived adult mesenchymal stem cells colonized on human pericardial matrix.;   Procedure: Surgery by sternotomy
Sponsors:   Fundació Institut Germans Trias i Pujol;   Germans Trias i Pujol Hospital
Not yet recruiting

Pages